- Current report filing (8-K)
02 March 2010 - 8:59AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
March 1, 2010
Date of Report (Date of earliest event reported)
OSI PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
0-15190
|
|
13-3159796
|
|
|
|
|
|
(State or other jurisdiction of
incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
41 Pinelawn Road
Melville, NY 11747
(Address of principal executive offices)
(631) 962-2000
(Registrants telephone number, including area code)
N/A
(Former name or former address,
if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material
pursuant to Rule
14a-12 under the
Exchange Act (17
CFR 240.14a-12)
o
Pre-commencement
communications
pursuant to Rule
14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement
communications
pursuant to Rule
13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
|
|
|
Item 8.01.
|
|
Other Events
.
|
On March 1, 2010, OSI Pharmaceuticals, Inc. (OSI) issued a press release confirming receipt
of an unsolicited proposal from Astellas Pharma Inc. to acquire OSI. A copy of the press release
is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
|
|
|
Item 9.01.
|
|
Financial Statements and Exhibits.
|
|
|
|
Exhibit No.
|
|
Description
|
99.1
|
|
Press release dated March 1, 2010.
|
-2-
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
Date: March 1, 2010
|
OSI PHARMACEUTICALS, INC.
|
|
|
By:
|
/s/ Barbara A. Wood
|
|
|
|
Barbara A. Wood
|
|
|
|
Senior Vice President, General
Counsel
and Secretary
|
|
-3-
EXHIBIT INDEX
|
|
|
Exhibit No.
|
|
Description
|
99.1
|
|
Press release dated March 1, 2010.
|
-4-
Osi Pharmaceuticals (NASDAQ:OSIP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Osi Pharmaceuticals (NASDAQ:OSIP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Osi Pharmaceuticals Inc. (MM) (NASDAQ): 0 recent articles
More News Articles